Fab Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.45 Cr
- Revenue Growth -54.34%
- Profit Growth -44.12%
- Ebitda -68.90%
- Net Worth 4.80%
- Total Assets 16.36%
About Fab Pharmaceuticals
Fab Pharmaceuticals Private Limited (FPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 May 2010 and has a history of 14 years and eight months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.45 Cr.
Kunal Rakhia, Teena Rakhia, and Piyush Rakhia serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233KA2010PTC053589
-
Company No.
053589
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 May 2010
-
Date of AGM
08 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Fab Pharmaceuticals Private Limited offer?
Fab Pharmaceuticals Private Limited offers a wide range of products and services, including Surgical & Medical Consumables, Surgical Disposables, Infusion Syringes & Supplies, Medical Tubes, Disposable Infusion Set, Pain Relief Drugs & Pharmaceuticals, Pain Killers.
Who are the key members and board of directors at Fab Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunal Rakhia
|
Director | 11-May-2010 | Current |
|
Teena Rakhia
|
Director | 11-May-2010 | Current |
|
Piyush Rakhia
|
Additional Director | 25-Jun-2013 | Current |
Financial Performance of Fab Pharmaceuticals.
Fab Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 54.34% decrease. The company also saw a substantial fall in profitability, with a 44.12% decrease in profit. The company's net worth moved up by a moderate rise of 4.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fab Pharmaceuticals?
In 2022, Fab Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Escape Ventures LlpPiyush Rakhia is a mutual person
-
Living Ventures Private Limited
Piyush Rakhia is a mutual person
Charges (Loans)
₹74.49 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.35 Cr
- Hdfc Bank Limited : 3.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Oct 2022 | Hdfc Bank Limited | ₹1.01 M | Open |
| 29 Sep 2022 | Others | ₹5.99 M | Open |
| 29 Sep 2022 | Others | ₹3.75 Cr | Open |
| 16 Jul 2021 | Hdfc Bank Limited | ₹3.00 Cr | Open |
How Many Employees Work at Fab Pharmaceuticals?
Unlock and access historical data on people associated with Fab Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fab Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fab Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.